The Inwardbound Introduction to Psychedelic Assisted-Therapy Programme director is Inwardbound co-founder Rob Coffey. Rob is a fully accredited psychotherapist (MIACP/ MSc/ BA Hons) and transpersonal therapist. Prior to becoming a psychotherapist, he had many years experience co-ordinating educational courses and lecturing in the field of higher education up to University Honors degree level (Level 8) .

A TEDx speaker, activist, somatic trauma specialist, #1 Best Selling Author, and yoga teacher & group facilitator, Atira Tan, is a powerful agent of transformation and change. She has touched the lives of thousands of women, men, and children around the world, supporting them through her 15 years of experience in various somatic and creative trauma recovery approaches. Atira has worked as a trauma integration specialist at Temple of the Way of Light ayahuasca centre in Peru and is now Head of Integration at Aya Healing retreats.

Dr Darragh Stewart Phd is the co-founder of Inwardbound, and post-doctoral plant geneticist who will be covering the science of psychedelics in the Introduction to Psychedelic Therapy course. He will also cover different types of psychedelics, their history and their uses.

Martin is a jungian psychotherapist, who trained as a transpersonal therapist in Dr Stan Grof's holiotropic states of consciousness. He is widely regarded as one of the world's leading experts on celtic shamanism. Martin also spent 30 years working in the Irish psychiatric services, including some pioneering collaborations with legendary Irish psychiatrist and psychedelic pioneer Dr Ivor Browne, who was a contemporary and colleague of Dr Stan Grof.

Sophie-Charlotte Alice Adler, MSc, is a psychologist, hypnotherapist, researcher and author. She has specialised in working with altered states of consciousness since 2017 and has been supervising ketamine infusions at Instituto Dr. Scheib in Mallorca since 2018. In Autumn 2020 she built up a private practice for Dr. Scheib in Berlin where Ketamine Therapy is offered. Ketamine (off-label use) is currently the only legally available and approved psychedelic substance. With the support of Dr Mario Scheib and Prof Revenstorf, Sophie Adler developed an innovative therapy method, the "Ketamine Hypnosis Package" (KHP).

Declan Hammond is a homeopath, transpersonal therapist and shamanic practitioner, co-founder and former director of The Irish School of Homeopathy. His life and work has been a passionate search for the most effective healing tools for himself and his patients. This journey has taken him all over the globe studying Eastern and Western approaches to healing and traditional shamanic practices. Declan has developed a unique synthesis of these ancient and modern healing techniques and works with individuals and groups to empower deep personal growth and spiritual development.

Graham has been interested in the therapeutic potential of psychedelic drugs since the late 1990s. This naturally evolved from his early interest in the interpretation of dreams, hypnosis and psychoanalysis.He qualified as a doctor in 2003 from the University of Birmingham and trained in psychiatry from 2006. In 2012, he was awarded an MSc in Neuroscience with distinction from Kings College London and focussed on the role of inflammation in the aetiology of depression. He worked as an NHS inpatient consultant psychiatrist from 2012 at Mill View Hospital in Hove and trained with Imperial College London in February 2018 to work as an assistant guide for the trial comparing psilocybin with escitalopram for depression.

Robert Krause, DNP, APRN-BC is Visiting Faculty at the Graduate Institute and a former faculty lecturer in the GEPN program at the Yale School of Nursing where he worked for the past 20 years. He has extensive experience in teaching including having taught courses at Western CT State University, Quinnipiac University, and the Yale School of Nursing. He coordinated the GEPN Clinical Psychiatric Nursing experience as well as lectured for Psychiatric and Mental Health Nursing and a professional issues course. His research has involved using yoga, meditation, and other practices to decrease aggression in-patient psychiatric populations. Currently, he researches the use of psilocybin for depression and also maintains a private psychiatric practice treating most major psychiatric conditions with therapy and pharmacology.

Henry Whitfield is an Association of Contextual Behavioural Science (ACBS) Peer-reviewed Acceptance and Commitment Therapy trainer, an Accredited Advanced TIR (PTSD therapy) Trainer, a Cognitive Behavioural Psychotherapist (MSc – CBT) and Visiting Research Fellow at Regent’s University – School of Psychotherapy and Psychology. He is a Phd candidate at the University of Maastricht in psychotherapeutic processes for psychedelic-assisted therapy. For over seven years Henry ran and supervised brief therapy for PTSD projects for Victim Support and Mind in London gun crime hot spots, using CBT and TIR.  

Henry has also trained over 1500 psychological therapists since 2003, supervising mental health professionals for ACT and Trauma work in the NHS. He is also a passionate integral thinker, publishing journal articles and book chapters on the integration of therapeutic models including, REBT-mindfulness, ACT-TIR-CBT, Person-centred-TIR. His psychedelic plant medicine path has changed how he does psychotherapy especially with self-concept issues. He has written, co-written and edited training manuals for ACT, TIR and FAP (relational psychodynamic). Now he focuses his research on the development of ACT-consistent models for psychedelic preparation and integration, with psychedelic process research for Regents University London. He is also author of a new model of psychological flexibility A Spectrum of Selves, tailored to a psychedelic therapy context published 2021 in Frontiers in Psychiatry.